Related Experiment Video
Updated: Jun 29, 2026

10:26
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
28.3K
Cervical Adenocarcinoma In Situ in Young Nulliparous Patient with Persistent ASC-US and Multiple-Type HPV Infections
Nikola Milic1, Marija Varnicic Lojanica1, Stefan Ivanovic2
1Užice General Hospital, 31000 Užice, Serbia.
Diagnostics (Basel, Switzerland)
|February 27, 2026
Summary
Adenocarcinoma in situ (AIS) is a severe cervical premalignant lesion often linked to persistent human papillomavirus (HPV) infection. This case highlights challenges in detecting glandular lesions, emphasizing caution with persistent low-grade cervical abnormalities, especially in younger patients.
Area of Science:
- Gynecologic Oncology
- Cervical Pathology
- Human Papillomavirus (HPV) Research
Background:
- Adenocarcinoma in situ (AIS) is the most severe premalignant lesion of cervical glandular epithelium.
- Persistent HPV infection is a primary risk factor for AIS, typically affecting women in their fourth decade.
- Current cervical cancer screening protocols, including HPV testing and cytology, have limitations in detecting glandular lesions.

